您的位置: 首页 > 农业专利 > 详情页

Compositions and methods for treating hematologic cancers targeting the SIRPalpha - CD47 interaction
专利权人:
University Health Network;The Hospital for Sick Children
发明人:
Wang, C. Y. Jean,Dick, John,Danska, Jayne,Jin, Liqing,Rajakumar, Sujeetha,Theocharides, Alexandre
申请号:
AU2020220183
公开号:
AU2020220183A1
申请日:
2020.08.21
申请国别(地区):
AU
年份:
2020
代理人:
摘要:
#$%^&*AU2020220183A120200910.pdf#####ABSTRACT: The invention relates to modulating the SIRPa - CD47 interaction in order to treat hematological cancer and compounds therefor. In some embodiments, there is provided 5 methods and uses of SIRPa polypeptides, fragments and fusion proteins for treating hematological cancer, preferably human acute myeloid leukemia.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充